ST. GALLEN, SWITZERLAND, March 19, 2024 /PRNewswire/ -- CSL Vifor today announced that Health Canada has authorized Ferinject (ferric carboxymaltose) for the intravenous (IV) treatment of iron ...
Results of a subanalysis from the FAIR-HF (Ferinject(R) Assessment in patients with IRon deficiency and Chronic Heart Failure) study demonstrate that correcting iron deficiency with Ferinject(R) ...
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221127005020/en/ CSL Vifor and Fresenius Kabi today ...
ST. GALLEN, Switzerland & BEIJING--(BUSINESS WIRE)-- Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results